Europe Therapeutic Drug Monitoring (TDM) Market Report 2016: Forecasts, Technologies & Strategies - France, Germany, Italy, Spain & UK

Dec 01, 2015, 03:45 ET from Research and Markets

DUBLIN, December 1, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/9h2nl2/2016_europe) has announced the addition of the "2016 Europe Therapeutic Drug Monitoring (TDM) Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.            

The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin. 

This new 291-page report from provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.  

During the next five years, the TDM market will undergo significant transformation.  These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 

Contains 291 pages and 61 tables 

Companies Mentioned:  

  • Abbott Laboratories
  • AdnaGen/Alere
  • Agilent Technologies
  • Bayer Healthcare
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

For more information visit http://www.researchandmarkets.com/research/9h2nl2/2016_europe

About Research and Markets 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: 
Laura Wood
+353-1-481-1716
press@researchandmarkets.net


SOURCE Research and Markets